Search Results - "Kataoka, Kazuhiko"

Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer by Sato, Toshihiko, MD, PhD, Teramukai, Satoshi, PhD, Kondo, Haruhiko, MD, PhD, Watanabe, Atsushi, MD, PhD, Ebina, Masahito, MD, PhD, Kishi, Kazuma, MD, PhD, Fujii, Yoshitaka, MD, PhD, Mitsudomi, Tetsuya, MD, PhD, Yoshimura, Masahiro, MD, PhD, Maniwa, Tomohiro, MD, Suzuki, Kenji, MD, PhD, Kataoka, Kazuhiko, MD, PhD, Sugiyama, Yukihiko, MD, PhD, Kondo, Takashi, MD, PhD, Date, Hiroshi, MD, PhD

“…Objective The study objective was to examine the incidence, risk factors, and mortality rate of acute exacerbation of interstitial lung diseases in patients…”
Get full text

Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study by Kawaguchi, Tomoya, Koh, Yasuhiro, Ando, Masahiko, Ito, Norimasa, Takeo, Sadanori, Adachi, Hirofumi, Tagawa, Tsutomu, Kakegawa, Seiichi, Yamashita, Motohiro, Kataoka, Kazuhiko, Ichinose, Yukito, Takeuchi, Yukiyasu, Serizawa, Masakuni, Tamiya, Akihiro, Shimizu, Shigeki, Yoshimoto, Naoki, Kubo, Akihito, Isa, Shun-Ichi, Saka, Hideo, Matsumura, Akihide

“…Oncogenic driver mutations are critical for lung cancer development and serve as therapeutic targets. However, their associations with environmental factors…”
Get full text

Surgery Outcomes for Pulmonary Metastases from Renal Cell Carcinoma by Choshi, Haruki, Watanabe, Mototsugu, Furukawa, Shinichi, Ujike, Hiroyuki, Kataoka, Kazuhiko

Get full text

Two Cases of Thymic Cancer in Patients with Lynch Syndrome by Watanabe, Mototsugu, Tanakaya, Kohji, Furukawa, Shinichi, Shiotani, Toshio, Sato, Yumiko, Taniguchi, Fumitaka, Kanaya, Nobuhiko, Aoki, Hideki, Sugano, Koukichi, Ishida, Hideyuki, Akagi, Kiwamu, Kataoka, Kazuhiko

“…We herein report two cases of thymic cancer with Lynch syndrome showing a high frequency of microsatellite instability and loss of mismatch repair protein…”
Get full text

Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201 by Yamamoto, Hiromasa, Soh, Junichi, Okumura, Norihito, Suzuki, Hiroyuki, Nakata, Masao, Fujiwara, Toshiya, Gemba, Kenichi, Sano, Isao, Fujinaga, Takuji, Kataoka, Masafumi, Terazaki, Yasuhiro, Fujimoto, Nobukazu, Kataoka, Kazuhiko, Kosaka, Shinji, Yamashita, Motohiro, Inokawa, Hidetoshi, Inoue, Masaaki, Nakamura, Hiroshige, Yamashita, Yoshinori, Hotta, Katsuyuki, Yoshioka, Hiroshige, Morita, Satoshi, Matsuo, Keitaro, Sakamoto, Junichi, Date, Hiroshi, Toyooka, Shinichi

“…It is shown that the postoperative adjuvant chemotherapy for non-small cell lung cancer (NSCLC) was associated with survival benefit in an elderly population…”
Get full text

Thoracoscopic Localization of Small Peripheral Pulmonary Lesions Using Percutaneous Computed Tomography-guided Pleural Dye Marking: A Retrospective Analysis by Kubo, Yujiro, Watanabe, Mototsugu, Choshi, Haruki, Matsubara, Kei, Shiotani, Toshio, Kataoka, Kazuhiko

“…Small pulmonary lesions are often difficult to localize during thoracoscopic surgery. We describe a new com-puted tomography (CT)-guided pleural dye-marking…”
Get full text

Resected case of stage IV pleomorphic carcinoma of the lung with long-term survival by Choshi, Haruki, Watanabe, Mototsugu, Ujike, Hiroyuki, Sato, Yumiko, Morito, Toshiaki, Sugimoto, Ryujiro, Kataoka, Kazuhiko

“…Background No established treatments for pulmonary pleomorphic carcinoma exist because of its rarity, and the prognosis is poorer than that of other non-small…”
Get full text

Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301 by Okumura, Norihito, Soh, Junichi, Suzuki, Hiroyuki, Nakata, Masao, Fujiwara, Toshiya, Nakamura, Hiroshige, Sonobe, Makoto, Fujinaga, Takuji, Kataoka, Kazuhiko, Gemba, Kenichi, Kataoka, Masafumi, Hotta, Katsuyuki, Yoshioka, Hiroshige, Matsuo, Keitaro, Sakamoto, Junichi, Date, Hiroshi, Toyooka, Shinichi

“…The aim of this multicenter, randomized phase II study was to analyze the feasibility and safety of alternate-day S-1, an oral fluoropyrimidine, for adjuvant…”
Get full text

Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study by Tamiya, Akihiro, Koh, Yasuhiro, Isa, Shun‐ichi, Kubo, Akihito, Ando, Masahiko, Saka, Hideo, Yoshimoto, Naoki, Takeo, Sadanori, Adachi, Hirofumi, Tagawa, Tsutomu, Kawashima, Osamu, Yamashita, Motohiro, Kataoka, Kazuhiko, Takenoyama, Mitsuhiro, Takeuchi, Yukiyasu, Watanabe, Katsuya, Matsumura, Akihide, Kawaguchi, Tomoya

“…Background To report the follow up data and clinical outcomes of the JME study (UMIN 000008177), a prospective, multicenter, molecular epidemiology examination…”
Get full text

Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701 by Soh, Junichi, Okumura, Norihito, Nakata, Masao, Nakamura, Hiroshige, Fukuda, Minoru, Kataoka, Masafumi, Kajiwara, Shinsuke, Sano, Yoshifumi, Aoe, Motoi, Kataoka, Kazuhiko, Hotta, Katsuyuki, Matsuo, Keitaro, Toyooka, Shinichi, Date, Hiroshi

“…The aim of this multicenter study was to determine the appropriate administration schedule for S-1, an oral fluoropyrimidine, for adjuvant chemotherapy in…”
Get full text

Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001 by Okumura, Norihito, Sonobe, Makoto, Okabe, Kazunori, Nakamura, Hiroshige, Kataoka, Masafumi, Yamashita, Motohiro, Nakata, Masao, Kataoka, Kazuhiko, Yamashita, Yoshinori, Soh, Junichi, Yoshioka, Hiroshige, Hotta, Katsuyuki, Matsuo, Keitaro, Sakamoto, Junichi, Toyooka, Shinichi, Date, Hiroshi

“…Background This multicenter study evaluated the feasibility of novel adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent, long-term…”
Get full text

Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR by Watanabe, Masaru, Kawaguchi, Tomoya, Isa, Shun-ichi, Ando, Masahiko, Tamiya, Akihiro, Kubo, Akihito, Saka, Hideo, Takeo, Sadanori, Adachi, Hirofumi, Tagawa, Tsutomu, Kawashima, Osamu, Yamashita, Motohiro, Kataoka, Kazuhiko, Ichinose, Yukito, Takeuchi, Yukiyasu, Watanabe, Katsuya, Matsumura, Akihide, Koh, Yasuhiro

“…Epidermal growth factor receptor (EGFR) mutations have been used as the strongest predictor of effectiveness of treatment with EGFR tyrosine kinase inhibitors…”
Get full text

A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer by Yamashita, Yoshinori, Kataoka, Kazuhiko, Ishida, Teruyoshi, Matsuura, Motoki, Seno, Noritomo, Mukaida, Hidenori, Miyahara, Eiji, Miyata, Yoshihiro, Okita, Riki, Shimizu, Katsuhiko, Watari, Masanobu, Okumichi, Tsuneo, Okada, Morihito

“…Recent clinical trials have shown significant survival benefits from postoperative adjuvant therapy for respectable nonsmall cell lung cancer (NSCLC). However,…”
Get more information

Left lung cancer accompanied with a persistent left superior vena cava; report of a case by Fujiwara, Toshiya, Shimoda, Atsushi, Nishikawa, Toshio, Kataoka, Kazuhiko, Matsuura, Motoki

“…A 77-year-old woman who had been treated for tongue cancer, esophageal cancer and laryngeal cancer, 25 years, 8 years and 8 months before respectively, was…”
Get more information

Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR by Watanabe, Masaru, Kawaguchi, Tomoya, Isa, Shun-ichi, Ando, Masahiko, Tamiya, Akihiro, Kubo, Akihito, Saka, Hideo, Takeo, Sadanori, Adachi, Hirofumi, Tagawa, Tsutomu, Kakegawa, Seiichi, Yamashita, Motohiro, Kataoka, Kazuhiko, Ichinose, Yukito, Takeuchi, Yukiyasu, Sakamoto, Kazuhiro, Matsumura, Akihide, Koh, Yasuhiro

“…The resistance to the EGFR tyrosine kinase inhibitors (TKI) is a major concern in non-small cell lung cancer (NSCLC) treatment. T790M mutation in EGFR accounts…”
Get full text

Lung cancer associated with pulmonary aspergillosis in the nodule of old mycobacterial infection by Nishikawa, Toshio, Kagawa, Tetsuya, Matsumi, Yuuki, Fujiwara, Toshiya, Kataoka, Kazuhiko, Matsuura, Motoki

“…A 66-year-old man was admitted to our hospital to examine abnormal shadow in the right lung in May 2009. Chest computed tomography (CT) showed a nodule in the…”
Get more information

Leiomyoma of the trachea; report of a case by Kataoka, Kazuhiko, Nishikawa, Toshio, Fujiwara, Toshiya, Matsuura, Motoki

“…Leiomyoma of the trachea is a rare benign tumor. The patient was a 44-year-old male with a chief complaint of cough. Chest X-ray and computed tomography (CT)…”
Get more information

Myxoid solitary fibrous tumor with rapid growth due to increased mucinous components: a case report by Kondo, Kaoru, Shiotani, Toshio, Furukawa, Shinichi, Watanabe, Mototsugu, Kataoka, Kazuhiko

“…Abstract Background Myxoid solitary fibrous tumors are defined as solitary fibrous tumors with ≥ 50% mucinous components. As they are a rare type of pleural…”
Get full text

EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery by Fujiwara, Toshiya, Shien, Kazuhiko, Matsuura, Motoki, Soh, Junichi, Yamamoto, Hiromasa, Takao, Soshi, Maki, Yuho, Ueno, Tsuyoshi, Sugimoto, Ryujiro, Suzawa, Ken, Okazaki, Mikio, Tao, Hiroyuki, Hayama, Makio, Kataoka, Masafumi, Sano, Yoshifumi, Inokawa, Hidetoshi, Yamashita, Motohiro, Kawamata, Osamu, Kataoka, Kazuhiko, Toyooka, Shinichi

“…Background Primary lung tumors are sometimes resected when either pleural dissemination (PD) or malignant pleural effusion (MPE) exists. This study clarified…”
Get full text

A case of bronchial atresia treated with right S6 segmentectomy using fluorescence navigation with indocyanine green by Watanabe, Mototsugu, Kondo, Kaoru, Furukawa, Shinichi, Shiotani, Toshio, Kataoka, Kazuhiko

“…Abstract Background Bronchial atresia is a congenital obstruction of the segmental or lobar bronchus that often leads to hyperinflation of the affected area…”
Get full text